Back
Range Cancer Therapeutics ETF Vs. Strategy Industry Stock Comparison
Sell
7
CNCR
Range Cancer Therapeutics ETF
Last Price:
$11.00
Seasonality Move:
-3.32%
Sell
42
MSTR
Strategy
Last Price:
$262.56
Seasonality Move:
-7.07%
Sell
7
Range Cancer Therapeutics ETF (CNCR)
is a Sell
Is Range Cancer Therapeutics ETF a Buy, Sell or Hold?
-
The current Range Cancer Therapeutics ETF [CNCR] share price is $10.83. The Score for CNCR is 7, which is 86% below its historic median score of 50, and infers higher risk than normal.
-
CNCR is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
42
Strategy (MSTR)
is a Sell
Is Strategy a Buy, Sell or Hold?
-
MSTR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CNCR Stock Price Chart
What is Range Cancer Therapeutics ETF's stock price today?
-
The Range Cancer Therapeutics ETF share price today is $10.83Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CNCR is experiencing buying pressure, which is a positive indicator for future bullish movement.
CNCR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.4 | Sell |
Relative Strength Index (14 RSI): | 36.15 | Sell |
Chaikin Money Flow: | 2685 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (11.24 - 12.56) | Sell |
Bollinger Bands (100): | (11.84 - 14.56) | Sell |
MSTR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -16.58 | Sell |
Relative Strength Index (14 RSI): | 42.2 | Sell |
Chaikin Money Flow: | 18568120 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (271.71 - 339.13) | Sell |
Bollinger Bands (100): | (258.91 - 384.07) | Sell |
CNCR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 11.04 | Sell |
20-day SMA: | 11.78 | Sell |
50-day SMA: | 12.09 | Sell |
200-day SMA: | 13.91 | Sell |
8-day EMA: | 11.15 | Sell |
20-day EMA: | 11.58 | Sell |
50-day EMA: | 12.17 | Sell |
200-day EMA: | 13.46 | Sell |
MSTR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 272.75 | Sell |
20-day SMA: | 297.16 | Sell |
50-day SMA: | 325.25 | Sell |
200-day SMA: | 235.44 | Buy |
8-day EMA: | 280.39 | Sell |
20-day EMA: | 294.66 | Sell |
50-day EMA: | 313.35 | Sell |
200-day EMA: | 251.3 | Buy |
Range Cancer Therapeutics ETF Earnings Growth & CNCR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Strategy Earnings Growth & MSTR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.03 per share, an increase next quarter of $37.64 per share, an increase this year of $2.96 per share, and an increase next year of $0.01 per share.
Range Cancer Therapeutics ETF Technical Analysis
Feb 25 | Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
25 | 26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Strategy Technical Analysis
Feb 25 | Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
25 | 26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |